ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Chicago, IL, USA:

Study of VYD2311 for the Prevention of COVID-19 (DECLARATION)

The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...

Not yet enrolling
COVID-19
Drug: VYD2311-SD
Drug: VYD2311-MD

Phase 3

Invivyd

Melrose Park, Illinois, United States and 18 other locations

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Chicago, Illinois, United States and 100 other locations

Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...

Enrolling
Covid19
Drug: STRI Formula
Drug: Placebo

Phase 2

Eyecheck

Oak Forest, Illinois, United States and 12 other locations

of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...

Active, not recruiting
COVID-19 Immunization
Influenza Immunization
Biological: IIV-HD + rC19 (dose 4)
Biological: IIV-HD + rC19 (dose 3)

Phase 1, Phase 2

Sanofi
Sanofi

Chicago, Illinois, United States and 11 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Chicago, Illinois, United States and 144 other locations

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech
BioNTech

Oak Brook, Illinois, United States and 28 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Chicago, Illinois, United States and 66 other locations

Locations recently updated

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Chicago, Illinois, United States and 215 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Chicago, Illinois, United States and 74 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Chicago, Illinois, United States and 33 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems